SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001798749-24-000026
Filing Date
2024-04-26
Accepted
2024-04-26 17:23:29
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS tmb-20231231xars.pdf ARS 3412113
  Complete submission text file 0001798749-24-000026.txt   4700737
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40544 | Film No.: 24885405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)